SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001038133-13-000034
Filing Date
2013-11-14
Accepted
2013-11-14 16:51:43
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q form10q.htm 10-Q 721937
2 AMENDMENT 3 TO INTERVET SUPPLY/LICENSE AGREEMENT ex10-1.htm EX-10.1 16527
3 AMENDMENT 12 TO CREDIT AND SECURITY AGREEMENT ex10-2.htm EX-10.2 207945
4 CEO CERTIFICATION ex31-1.htm EX-31.1 16446
5 CFO CERTIFICATION ex31-2.htm EX-31.2 14843
6 CEO AND CFO CERTIFICATION ex32-1.htm EX-32.1 9477
  Complete submission text file 0001038133-13-000034.txt   3342259

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT hska-20130930.xml EX-101.INS 298261
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20130930.xsd EX-101.SCH 25917
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hska-20130930_cal.xml EX-101.CAL 37528
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hska-20130930_def.xml EX-101.DEF 47540
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hska-20130930_pre.xml EX-101.PRE 141599
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE hska-20130930_lab.xml EX-101.LAB 209107
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22427 | Film No.: 131220989
SIC: 2836 Biological Products, (No Diagnostic Substances)